Gain Therapeutics, Barcelona
A company from Barcelona (Barcelona) included in the Catalonia Industry Suppliers directory
Gain Therapeutics, Barcelona
Barcelona (Barcelona)
Activity
Gain Therapeutics is redefining drug discovery with its SEE-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding, including lysosomal storage disorders. Gain was originally established in 2017 with the support of its founders and institutional investors such as TiVenture, 3B Future Health Fund (previously known as Helsinn Investment Fund) and VitaTech.
Profile
Service Providers
Technologies
- Omic Sciences
Products, services and capacities
- Protein misfolding
- Site-Directed Enzyme Enhancement Therapy (SEE-Tx™) platform
- Structurally Targeted Allosteric Regulators (STARs)
Applications
- Health & Healthcare Services
- Pharmaceutical Industry
- R&D
Activity classification (NACE)
- 8299 - Other business support service activities n.e.c.
Last time updated January 2022
More About the search engine.
- About this directory
About this directory
What companies are included? Discover our company inclusion criteria.
- Join this directory
Join this directory
Are you a Catalan supplier? Register your company or update your information.
- Can´t find your suppliers?
Can´t find your suppliers?
Tell us what you are looking for and we’ll contact you from the Supplier Search Service.
Collaborators.
We teamed up with local business associations and clusters to create the Catalonia Industry Suppliers.
